A multicenter, parallel group flexible dose study with a double blind, randomized, placebo controlled phase and an open-label phase to evaluate the quality of erections in men with erectile dysfunction treated with sildenafil citrate

Trial Profile

A multicenter, parallel group flexible dose study with a double blind, randomized, placebo controlled phase and an open-label phase to evaluate the quality of erections in men with erectile dysfunction treated with sildenafil citrate

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 May 2016

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 16 Jan 2013 New source identified and integrated (German Clinical Trials Register record: DRKS00004151).
    • 01 Mar 2008 Results have been published in The Journal of Sexual Medicine.
    • 10 Aug 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top